Galapagos shares soar on $4-6 billion hopes for new drug

Strong results for an experimental drug that promises to disrupt the rheumatoid arthritis market lifted shares in Belgian-Dutch firm Galapagos to an all-time high on Wednesday, as analysts forecast multibillion-dollar sales.

from Reuters: Health https://ift.tt/2x6ACix
via IFTTT

• Tweet
• Share
• Share
• Share
• Share